Dr. Miguel Arce Rentería, a neuropsychologist at Columbia University, comments that treatment that focuses on social issues may hold off the worst of Alzheimer’s Disease for years.
New research from Columbia Neurologist Dr. Claire Riley and Nurse Practitioner Libby Levine sheds light on the potential complications of B-cell suppressing therapies in women with multiple sclerosis.
A new collaborative study by Drs. Martin Picard and Philip L. De Jager examines the potential link between the brain's mitochondria and a person's psychological stress.
Dr. Jason Carmel, associate professor of neurology, is developing a nerve stimulation therapy at Columbia that may eventually allow people with spinal cord injuries to regain function of their arms
A team of Columbia University researchers led by Martin Picard, PhD, discovered that human cells with impaired mitochondria respond by kicking into higher gear and expending more energy
The Carol and Gene Ludwig Center for Research on Neurodegeneration Will Bring Novel Approaches to Alzheimer’s and Other Neurodegenerative Disease Research
Students from historically Black colleges and universities (HBCUs) joined Columbia biomedical research laboratories for a summer of science, as part of CUIMC’s newest summer program
For more than 20 years, scientists have known that people with hypertension, diabetes, high cholesterol, or obesity have a higher likelihood of developing Alzheimer’s disease.
A new initiative led by Columbia University and the n-Lorem Foundation will develop personalized therapies for individuals with "nano-rare" genetic forms of ALS and treat them for free, for life.
Please join in welcoming Dr. Churl-Su Kwon to our faculty as assistant professor of neurological sciences (in Neurology, Epidemiology, Neurological Surgery, and the Gertrude H. Sergievsky Center)